logo
Select company
Select metric
-36.8%EBIT Margin
VS
Market
18
Sector
49
Industry
74
History
100
$ -1Close
$ -1 - $ -1 52-Week Range
Ticker Information

Ticker

IGMS

Company Name

IGM BIOSCIENCES INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

IGM BIOSCIENCES INC - EBIT Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

IGMS - EBIT % Historical data
DateEarning Before Interest & Taxes (EBIT)EBIT MarginRevenues
6/30/2025$ -53.38M-36.8%$ 145.05M
3/31/2025$ -198.87M-7417.79%$ 2.68M
12/31/2024$ -195.79M-7308.51%$ 2.68M
9/30/2024$ -219.6M-7525.74%$ 2.92M
6/30/2024$ -219.92M-7554.79%$ 2.91M
3/31/2024$ -236.33M-11227.17%$ 2.1M
12/31/2023$ -245.74M-11537%$ 2.13M
9/30/2023$ -237.86M-12850.41%$ 1.85M
6/30/2023$ -234.15M-13995.76%$ 1.67M
3/31/2023$ -228.43M-14357.64%$ 1.59M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • IGM BIOSCIENCES INC's latest trailing twelve months (TTM) EBIT % stands at 0%.
  • Over the past 5 years, IGM BIOSCIENCES INC's average EBIT % has been -15540.82%.
  • The median EBIT % for IGM BIOSCIENCES INC during this period was -11537%
  • IGM BIOSCIENCES INC reached its highest EBIT % over the past 5 years at -36.8%.
  • The lowest EBIT % recorded by IGM BIOSCIENCES INC in the same timeframe -56091.53%

IGM BIOSCIENCES INC's EBIT % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT % Benchmarks
CompanyEBIT %
ATRA : ATARA BIOTHERAPEUTICS INC 5.27%CHRS : COHERUS ONCOLOGY INC 136.5%STRO : SUTRO BIOPHARMA INC -174.93%MGNX : MACROGENICS INC -20.84%IPSC : CENTURY THERAPEUTICS INC -18.85%KPTI : KARYOPHARM THERAPEUTICS INC -57.38%DOMH : DOMINARI HOLDINGS INC -36.01%ZYXI : ZYNEX INC -13.91%FBIO : FORTRESS BIOTECH INC -0.34%MGX : METAGENOMI INC -267.38%

Definition of EBIT Margin

[Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
EBIT / Revenues
(=) EBIT %
EBIT % for IGM BIOSCIENCES INC is calculated as follows: EBIT [ $ -71.55M ] / Revenues [ $ 0 ]
(=) EBIT % [ 0% ]

IGMS - EBIT Margin, Last 5 years

-56091.53%

Minimum

Jun 30, 2022

-36.8%

Maximum

Jun 30, 2025

-15540.82%

Average

-11537%

Median

EBIT % Benchmark Analysis

The chart above depicts the distribution of EBIT % for companies in the Total Stock Market. The average EBIT % of the companies is 9.54% with a standard deviation of 23.96%.
The following table provides additional summary stats:
EBIT % in the Market:
filtered constituents3.26K
min-73.16%
max83.08%
average9.54%
median9.01%
std23.96%